Related by context. All words. (Click for frequent words.) 65 OncoVEX GM CSF 65 Traficet EN 64 Oncophage 64 cancer immunotherapies 64 Marqibo 64 TREANDA 64 MabCampath 63 DCVax R Brain 63 perifosine 63 valopicitabine 63 PROSTVAC TM 63 immunotherapeutic 63 Amrubicin 63 obatoclax 63 HuMax CD4 63 SinuNase 63 TELCYTA 63 IMA# 63 DCVax Brain 62 panitumumab 62 maribavir 62 HuMax CD# 62 elacytarabine 62 trabectedin 62 pralatrexate 62 oral ridaforolimus 62 IMGN# 62 YONDELIS 62 ofatumumab 62 CoFactor 62 FavId 62 Allovectin 7 R 61 RhuDex ® 61 GRNVAC1 61 ADVEXIN 61 TORISEL 61 OncoVEX 61 Azedra 61 satraplatin 61 M Vax 61 decitabine 61 MyVax R 61 Sym# 61 thymalfasin 61 FOLOTYN 61 Valortim 61 PXD# 61 amrubicin 61 MyVax 61 Anthim 61 TYZEKA 61 Diamyd ® 61 Taxotere ® 61 CD# antibody [001] 61 T DM1 61 IRX 2 61 talactoferrin 61 BiovaxID TM 61 PROCHYMAL 60 relapsed multiple myeloma 60 rilonacept 60 DCVax ® 60 milatuzumab 60 ixabepilone 60 ganetespib 60 L BLP# 60 Civacir 60 Targretin 60 EndoTAG TM -1 60 Fludara 60 nitazoxanide 60 ROTARIX 60 Allovectin 7 ® 60 blinatumomab 60 Fodosine 60 XmAb# 60 huC# DM4 60 MAGE A3 ASCI 60 Mepact 60 OPAXIO 60 TRIOLEX 60 SinuNase TM 60 HspE7 60 Locteron 60 otelixizumab 60 Altastaph 60 Jevtana 60 Virulizin ® 60 tivozanib 60 ponatinib 60 OvaRex ® MAb 60 TroVax 60 oritavancin 60 pomalidomide 60 Revimmune 60 lintuzumab 60 CYT# 60 cilengitide 60 Epratuzumab 60 DXL# 59 L MTP PE 59 Cethrin 59 HGS ETR1 59 BiTE antibody 59 BEXXAR 59 mertansine 59 VELCADE 59 Ceflatonin 59 EFAPROXYN 59 Clolar 59 VitiGam 59 GeoVax vaccine 59 Herceptin trastuzumab 59 BAY #-# 59 Telatinib 59 nanoviricide 59 ZEVALIN 59 Personalized Immunotherapy 59 Restanza 59 Allovectin 7 59 #D#C# 59 follicular non 59 SEBIVO 59 humanized anti 59 eniluracil 59 CR# vcMMAE 59 Bezielle 59 Alocrest 59 MOZOBIL 59 Velcade bortezomib 59 OHR/AVR# 59 FTY# 59 mapatumumab 59 ASA# 59 methylnaltrexone 59 Tarceva TM 59 Onrigin 59 monoclonal antibody 59 INT# [002] 59 HCD# [002] 59 PEG SN# 59 ZADAXIN 59 bendamustine 59 PrevOnco 59 glufosfamide 59 Leukine 59 omacetaxine 59 telbivudine 59 mifamurtide 59 StemEx R 59 pradefovir 59 samalizumab 59 MYDICAR ® 59 tocilizumab 58 HuMax EGFr 58 HQK 58 GVAX 58 Trastuzumab 58 TOCOSOL Paclitaxel 58 Onco TCS 58 veltuzumab 58 cetuximab Erbitux ® 58 Tavocept 58 Urocidin 58 RGB # 58 CBLC# 58 NEUMUNE 58 Azixa 58 Fludara ® 58 Ilaris 58 INGN 58 MAXY alpha 58 Temsirolimus 58 Genasense 58 StaphVAX 58 tesmilifene 58 rindopepimut 58 Gleevec imatinib mesylate 58 Treanda 58 Vivaglobin 58 Vectibix panitumumab 58 antibody MAb 58 anti EGFR antibody 58 Viramidine 58 Pralatrexate 58 ELACYT 58 biologic therapy 58 Phase Ib study 58 DCVax 58 rhThrombin 58 Rexin G 58 Imprime PGG 58 carfilzomib 58 registrational trial 58 NeuVax 58 KNS # 58 BioNumerik 58 enzastaurin 58 Zolinza 58 trastuzumab DM1 T DM1 58 PSMA ADC 58 CANCIDAS 58 eltrombopag 58 DEB# 58 Phase 2a trial 58 Defibrotide 58 SUTENT 58 belinostat 58 TEMODAL 58 Phase 2b trial 58 Aptivus ® 58 Folotyn 58 MGCD# [001] 58 Proxinium TM 58 Evoltra 58 dasatinib 58 DermaVir Patch 58 VIDAZA 58 Alemtuzumab 58 Virulizin R 58 Dacogen injection 58 dacetuzumab 58 Vectibix 58 CCX# 58 nanoviricides 58 Amplimexon 58 picoplatin 58 Valortim R 58 gastrointestinal stromal tumors GIST 58 atacicept 58 pertuzumab 58 ALN TTR# 58 Loramyc R 58 AP# [003] 58 ZADAXIN ® 58 phase IIb clinical 58 Campath alemtuzumab 58 oral prodrug 58 Pixantrone 58 Pradefovir 58 Advexin 58 UPLYSO 58 recurrent GBM 58 Panitumumab 58 elotuzumab 58 OXi# 58 metastatic renal cell carcinoma 58 ASONEP 58 bafetinib 58 ALN VSP 58 neratinib 58 vemurafenib 58 REMUNE R 58 Carfilzomib 58 imatinib mesylate Gleevec 58 ATL# [001] 58 Specifid 58 EOquin 57 INCB# [001] 57 velafermin 57 zanolimumab 57 CD# monoclonal antibody 57 canakinumab 57 immunotherapy 57 Multikine 57 DAVANAT 57 AeroLEF TM 57 subcutaneous formulation 57 Rituximab 57 HGS ETR2 57 vidofludimus 57 B CLL 57 INCB# [002] 57 Nanobody 57 romidepsin 57 Aflibercept 57 ZK EPO 57 zalutumumab 57 OMAPRO 57 Tarvacin 57 Panzem R NCD 57 Factor VIIa 57 hematological cancers 57 mAb 57 Vidaza 57 Hycamtin 57 registrational 57 DCVax ® Brain 57 reslizumab 57 Menveo 57 OncoVex 57 CHOP chemotherapy 57 TYKERB 57 radezolid 57 rFIXFc 57 Mozobil 57 APOPTONE 57 investigational monoclonal antibody 57 epratuzumab 57 Onconase 57 PROVENGE 57 LEUKINE 57 JAK inhibitor 57 ACZ# 57 Icatibant 57 ARIKACE 57 Degarelix 57 trastuzumab Herceptin 57 tanespimycin 57 Prochymal 57 immunomodulator 57 INTELENCE 57 ceftaroline 57 Clofarabine 57 axitinib 57 IMC A# 57 Tamibarotene 57 phase IIa clinical 57 immunotherapies 57 Phase IIIb clinical 57 Reolysin 57 Tovaxin 57 relapsed SCLC 57 dasatinib Sprycel ® 57 palonosetron 57 metastatic CRC 57 PROMACTA 57 eculizumab 57 proteasome inhibitor 57 alvespimycin 57 Blinatumomab 57 BENLYSTA 57 AEG# 57 Theratope 57 PEG interferon 57 HuLuc# 57 zileuton 57 GV# [001] 57 FluCide 57 MyVax ® 57 lenalidomide Revlimid R 57 liposomal formulation 57 forodesine 57 Gefitinib 57 MVA BN R 57 ChronVac C ® 57 bevacizumab Avastin 57 albinterferon alfa 2b 57 Daclizumab 57 PRTX 57 Tarceva erlotinib 57 PANVAC VF 57 anticancer therapy 57 4CMenB 57 humanized monoclonal antibody 57 Reverset 57 ONCONASE 57 pixantrone 57 immunotherapeutics 57 HCV 57 Neuradiab 57 vinorelbine 57 Satraplatin 57 CINTREDEKIN BESUDOTOX 57 ZOSTAVAX 57 CTAP# Capsules 57 Numax 57 forodesine hydrochloride 57 Symadex 57 relapsed refractory 57 Amigal 57 pediatric acute lymphoblastic 57 sapacitabine 57 SCCHN 57 Vaxfectin 57 Kepivance 57 nilotinib 57 Aurexis 57 Pazopanib 56 Gleevec imatinib 56 IRESSA 56 standard chemotherapy regimen 56 PLK1 SNALP 56 ONCASPAR 56 Perifosine 56 AutovaxID TM 56 LymphoStat B 56 Dendreon Provenge 56 SNT-MC#/idebenone 56 Bendamustine 56 histone deacetylase HDAC inhibitor 56 ZOLINZA 56 humanized antibodies 56 Sebivo 56 anticancer compound 56 CIMZIA TM 56 trastuzumab DM1 56 PD LID 56 daclizumab 56 mAbs 56 T#I [002] 56 Cerashield 56 metastatic melanoma 56 IL# PE#QQR 56 Nexavar ® 56 vismodegib 56 Vitaxin 56 chronic myeloid leukemia CML 56 custirsen 56 castration resistant prostate cancer 56 Tovaxin ® 56 Bortezomib 56 PROSTVAC VF 56 GRN# 56 Neulasta ® 56 ONTAK 56 ALN RSV# 56 azacitidine 56 MYDICAR 56 ILLUMINATE 56 Japanese Encephalitis vaccine 56 docetaxel Taxotere ® 56 G#DT 56 sipuleucel T 56 mCRC patients 56 TransVax TM 56 Insegia 56 TroVax ® 56 Ceftobiprole 56 Cytolin ® 56 vosaroxin 56 Ceftaroline 56 Neuvenge 56 NeuroVax TM 56 Orapred ODT 56 Glufosfamide 56 Vandetanib 56 Combidex 56 Taxotere R 56 FOLOTYN ® 56 orBec R 56 MoxDuo IR 56 bevacizumab Avastin ® 56 cancer immunotherapy 56 Actimmune ® 56 NEUPOGEN 56 oncolytic virus therapies 56 Ixempra 56 CBLB# 56 Interferon alfa 56 PEG INTRON 56 anti CD# antibodies 56 Phase Ib II 56 vandetanib 56 Talabostat 56 huN# DM1 56 nimotuzumab 56 bazedoxifene 56 mRCC 56 Cethromycin 56 radiation sensitizer 56 clofarabine 56 EndoTAG TM 56 ZYBRESTAT fosbretabulin 56 liver metastases 56 randomized Phase 56 BRAF V# mutation 56 Actemra 56 BRAF inhibitor 56 Golimumab 56 #I TM# 56 Guanilib 56 randomized Phase III 56 JAK1 56 thalidomide Thalomid 56 Alpharadin 56 palifosfamide 56 posaconazole 56 Gemzar ® 56 refractory Hodgkin lymphoma 56 lumiliximab 56 Quinamed 56 Navelbine ® 56 Avastin bevacizumab 56 pegfilgrastim 56 fluoropyrimidine 56 Ofatumumab 56 HEPLISAV 56 targeted antifolate 56 Tarmogen 56 DCVax R 56 Stimuvax 56 recurrent glioma 56 humanized antibody 56 OvaRex R 56 erlotinib Tarceva ® 56 RDEA# 56 cangrelor 56 brentuximab vedotin 56 Lucanix R 56 teriflunomide 56 orBec 56 TBC# 56 chemotherapeutic drug 56 ruxolitinib 56 Cimzia R 56 aflibercept 56 MAXY G# 56 Cotara 56 indolent NHL 56 Removab 56 fingolimod 56 targeting CD# 56 EOquin TM 56 Tesetaxel 56 Aplidin 56 Chrysalin 56 Xcytrin 56 KRAS wild 56 Xanafide 56 Erlotinib 56 investigational humanized monoclonal antibody 56 Dacogen 56 Targretin capsules 56 Rituxan rituximab 56 Actemra tocilizumab 56 Plenaxis R 56 ERBITUX 56 romiplostim 56 abiraterone acetate 56 APF# 56 Noxafil 56 Alzhemed TM 56 Dalbavancin 56 phase IIb 56 5-FU/LV 56 anti CD3 monoclonal 56 ularitide 56 EDEMA3 55 Torisel 55 antiviral activity 55 BLA submission 55 cutaneous T cell 55 ADVEXIN p# therapy 55 MVA BN 55 T Pred 55 MEK inhibitors 55 YERVOY 55 Copegus ribavirin 55 CIMZIA ™ 55 Elotuzumab 55 Riquent 55 relapsing multiple sclerosis 55 metastatic castration resistant 55 raxibacumab 55 Valortim ® 55 BiTE 55 HGS# 55 Onalta ™ 55 Æterna Zentaris 55 Irinotecan 55 phenoxodiol 55 indolent follicular non 55 viral kinetics 55 Omacetaxine 55 dacarbazine 55 chlorambucil 55 HepaGam B 55 CYC# 55 farletuzumab 55 DAVANAT R 55 Alferon N 55 TELINTRA 55 telaprevir VX 55 GED aPC 55 Locteron ® 55 fidaxomicin 55 anticancer therapies 55 subcutaneously administered 55 G CSF 55 CCR5 antagonist 55 Urocidin TM 55 anti CD# monoclonal 55 panitumumab Vectibix 55 PEGylated 55 EpCAM 55 galiximab 55 HCV protease inhibitor 55 Phase #b/#a clinical 55 entinostat 55 IgG1 monoclonal antibody 55 HER2 positive metastatic breast 55 Curaxin CBLC# 55 celgosivir 55 humanized monoclonal antibodies 55 Genasense R 55 alefacept 55 oral antiviral 55 ZYBRESTAT 55 CD# antibodies 55 nonclinical studies 55 oncolytic 55 Genasense ® 55 favorable pharmacokinetic profile 55 pegylated interferon alfa 2b 55 Annamycin 55 HuMax TAC 55 Zerenex 55 UVIDEM 55 refractory multiple myeloma 55 Vicinium TM 55 PLX cells 55 biologic therapies 55 MEPACT 55 trastuzumab Herceptin R 55 iclaprim 55 PEG Interferon lambda 55 BCR ABL inhibitors 55 Dapagliflozin 55 Phase IIb clinical trials 55 dirucotide 55 temsirolimus 55 acyclovir Lauriad R 55 dose cohort 55 anti idiotype 55 Protexia R 55 pharmacokinetic PK study 55 relapsed refractory multiple myeloma 55 ISTODAX 55 PrevOnco ™ 55 Cinryze 55 SNT MC# 55 Arzerra 55 ELND# 55 ALN TTR 55 maraviroc 55 TMC# [002] 55 Loramyc ® 55 DexaSite 55 voreloxin 55 plus dexamethasone 55 immunotherapeutic vaccine 55 pegylated interferon alpha 55 Phase 1b 55 investigational immunotherapy 55 personalized immunotherapy 55 Bicifadine 55 etanercept Enbrel 55 Pemetrexed 55 surrogate endpoint 55 ongoing Phase 1b 55 orphan medicinal product 55 Neurodex 55 Onalta 55 ENMD # 55 Epoetin alfa 55 Rituxan MabThera 55 PRT# 55 non metastatic osteosarcoma 55 pegylated interferons 55 Twinrix 55 PI3K/Akt pathway inhibitor 55 IAP inhibitor 55 GVAX immunotherapy 55 adecatumumab 55 PDE4 inhibitor 55 imatinib Gleevec ® 55 refractory metastatic colorectal cancer 55 NXL# 55 bortezomib 55 follicular NHL 55 dose cohorts 55 Phase Ib clinical 55 Hepatocellular Carcinoma HCC 55 docetaxel Taxotere R 55 HERmark 55 Panzem 55 filgrastim 55 FOLFOX4 55 Clolar ® 55 EGFr 55 Elvitegravir 55 Pentacel 55 Evoltra TM 55 Fx #A 55 TKM ApoB 55 palifermin 55 APTIVUS 55 idiotype vaccine 55 mcg dose 55 drug ISA# 55 AQ4N 55 virus HCV protease inhibitor 55 pegylated liposomal doxorubicin 55 Plicera 55 Xcellerated T Cells 55 tgAAC# 55 gastrointestinal stromal tumors 55 immunotherapeutic agent 55 somatostatin analogue 55 ALN PCS 55 Phase IIa clinical 55 Phase Ib 55 VIR# 55 anti leukemic 55 Cimzia ® certolizumab pegol 55 REOLYSIN ® 55 telaprevir 55 omega interferon 55 AzaSite Plus 55 Multimeric 55 Canvaxin TM 55 relapsed leukemia 55 YONDELIS R 55 CMV disease 55 vascular disrupting agent 55 refractory CLL 55 drug conjugate 55 liprotamase 55 BrachySil 55 Pimavanserin 55 talabostat 55 ACTEMRA 55 TAFA# 55 Interferon alpha 55 Junovan 55 hepatitis C HCV 55 Belimumab 55 EndoTAGTM 1 55 MAA submission 55 angiogenesis inhibitor 55 Pertuzumab 55 TRISENOX 55 CD3 monoclonal antibody 55 ridaforolimus 55 Zelrix 55 MNTX 55 thrombopoietin 55 EndoTAG 55 Engerix B 55 follicular lymphoma 55 Diamyd R 55 liposomal doxorubicin 55 EGFR antibodies 55 tolevamer 55 ROTATEQ 55 VPRIV 55 Revlimid lenalidomide 55 Acute Radiation Syndrome ARS 55 gemcitabine carboplatin 55 SAR# [004] 55 atrasentan 55 IDM Pharma 55 Catena ® 55 EGFR inhibitors 55 hA# 55 pan HDAC inhibitor 55 multicenter Phase 55 Raptiva ® 55 IAP inhibitors 55 recurrent NSCLC 55 torezolid phosphate 55 BAL# [002] 55 Aryplase 55 IMC #B 55 XL# [003] 55 refractory chronic lymphocytic 55 Omigard 55 MabThera rituximab 55 multicenter Phase II 55 RAPAFLO 55 NEUVENGE 55 RECOTHROM 55 Carboplatin 55 busulfan 55 Dasatinib 55 cell malignancies 55 Abiraterone acetate 55 GvHD 54 VLP vaccine 54 oral taxane 54 Plenaxis TM 54 NVA# 54 RG# [001] 54 T#I mutation 54 ORENCIA R 54 Opexa 54 cetuximab Erbitux 54 volociximab 54 MT#/MEDI-# 54 INC# 54 Alinia 54 rituximab 54 Chemophase 54 Doxil ® 54 vorinostat 54 vernakalant 54 Aviptadil 54 imatinib Gleevec 54 ChronVac C R 54 Omapro 54 REVLIMID 54 Mycograb 54 deforolimus 54 Triolex 54 interferon alfa 54 AVADO 54 preclinically 54 EGRIFTA TM 54 docetaxel chemotherapy 54 ZENPEP 54 trivalent influenza vaccine 54 Evoltra R 54 anti CD# antibody 54 targeted radiotherapeutic 54 Clavis Pharma 54 CCR5 receptor antagonist 54 TheraCIM 54 GALNS 54 DU #b 54 autologous cellular immunotherapy 54 Oncaspar 54 comparator arm 54 locoregional 54 Phenoptin 54 Vectibix monotherapy 54 ProLindac 54 darapladib 54 ribavirin RBV 54 ofatumumab HuMax CD# 54 Hemopurifier 54 ipilimumab 54 JVRS 54 efalizumab 54 depsipeptide 54 tafamidis 54 CEQ# 54 virotherapy 54 THALOMID 54 bicalutamide 54 Kahalalide F 54 liposome tumor 54 oropharyngeal candidiasis 54 Doxil 54 anticancer agent 54 TLR9 agonist 54 Phase #/#a trial 54 Arcalyst 54 TYGACIL 54 PNT# 54 Archexin 54 rhIL 7 54 relapsed ovarian cancer 54 BRIM2 54 Tasigna 54 Firazyr 54 Fibrillex TM 54 MAGE A3 54 cetuximab Erbitux R 54 GRN#L 54 Cx# [002] 54 GammaCan 54 TACI Ig 54 Fibrin Pad 54 Campath ® 54 STELARA 54 ACTEMRA TM 54 ApoB SNALP 54 TG# [003] 54 RAPTIVA 54 INTERCEPT platelets 54 peg IFN 54 refractory chronic myeloid 54 NY ESO 54 daptomycin 54 NEBIDO 54 tyrosine kinase inhibitor 54 nucleotide analogs 54 anti CD3 54 BARACLUDE R 54 Cimzia ® 54 Myocet 54 seliciclib 54 Ceplene 54 MT# MEDI 54 MGd 54 superficial bladder cancer 54 tremelimumab 54 AA amyloidosis 54 preclinical studies 54 severe hypercholesterolemia 54 RNAi therapeutic targeting 54 Increlex ® 54 Hyphanox 54 IIa trial 54 bortezomib Velcade 54 MBP# [001] 54 rituximab Rituxan 54 Phase #b/#a 54 AMEVIVE 54 confirmatory Phase III 54 Gamunex 54 Arzerra ofatumumab 54 telaprevir dosed 54 Gliadel Wafer 54 prophylactic vaccine 54 investigational therapies 54 Intercell vaccine 54 SUCCEED trial 54 Pirfenidone 54 Mycamine 54 NPC 1C 54 Laquinimod 54 TRO# 54 NV1FGF 54 Romiplostim 54 CAELYX 54 GVAX R 54 oral FTY# 54 MAbs 54 interferon alpha 54 ustekinumab 54 recurrent ovarian cancer 54 doripenem 54 KRAS status 54 Sphingomab TM 54 antiangiogenic therapy 54 lorvotuzumab mertansine 54 goserelin 54 COPAXONE ® 54 INTEGRILIN ® 54 IDX# 54 Arranon 54 MAb 54 synthetic retinoid 54 ProSavin 54 octreotide implant 54 cleavable linker 54 NP2 Enkephalin 54 cinacalcet HCl 54 APTIVUS r 54 relapsing remitting multiple sclerosis 54 AGGRASTAT R 54 Metastatic Melanoma 54 MEK inhibitor 54 DR Cysteamine 54 FOLFOX 54 Hepsera 54 PolyActive ® 54 Canvaxin 54 interferon gamma 1b 54 Lenalidomide 54 TAXUS Element Stent System 54 APTIVUS R 54 Hodgkin lymphoma NHL 54 Cimzia TM 54 tumor specific antigen 54 lentiviral vector 54 Kevetrin 54 MKC# MT 54 DOXIL 54 Asentar 54 Ketotransdel 54 metastatic malignant melanoma 54 carboplatin paclitaxel 54 relapsed MM 54 proteasome inhibitors 54 TYSABRI 54 FOLFIRI 54 phase IIb trial 54 alvimopan 54 Actimmune R 54 Nanobodies 54 telomerase therapeutic 54 PROVENGE sipuleucel T 54 Rituxan 54 chemotherapy induced neutropenia 54 indibulin 54 anidulafungin 54 Bavituximab 54 Litx 54 tamibarotene 54 Soliris TM eculizumab 54 Zirgan 54 plus gemcitabine 54 Extavia 54 therapeutic monoclonal antibody 54 XL# XL# 54 Pegintron 54 protein kinase inhibitor 54 Xencor XmAb 54 initiate Phase 1b 54 GVAX Pancreas Vaccine 54 DOS# 54 HPV-#/# 54 erlotinib Tarceva 54 vaccines oncolytic virus 54 RAV# 54 Oral NKTR